Drug intelligence / Profile preview

Qiangji Wan

Development stage: Unknown
Modality: Small Molecules
Administration: Oral

Overview

Qiangji Wan (强脊丸) is a traditional Chinese medicine formulation used primarily for musculoskeletal and rheumatic conditions, particularly ankylosing spondylitis. The name translates to "Strengthen the Spine Pill." It is typically composed of a combination of herbal ingredients designed to tonify the kidney and liver, strengthen bones and tendons, dispel wind-dampness, and relieve pain. Its mechanism of action is based on traditional Chinese medicine theory rather than modern pharmacology; it aims to regulate immune function, reduce inflammation, improve circulation in affected areas, and alleviate symptoms associated with chronic inflammatory diseases such as ankylosing spondylitis[2]. Clinical observations have reported its use in pediatric cases of ankylosing spondylitis.

Brand names: Qiangji Wan
Other names: 强脊丸

Beyond the preview

Go deeper on Qiangji Wan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qiangji Wan.

Explore the full profile